Introduction {#s1}
============

Acute kidney injury (AKI) is common \[[@SFV130C1]\], dangerous \[[@SFV130C2]--[@SFV130C5]\] and costly \[[@SFV130C1]\]. Unfortunately, AKI care is also often poor \[[@SFV130C6], [@SFV130C7]\]. Education must play a role in addressing this, but our previous work has shown that knowledge gaps are still evident even when AKI teaching is established \[[@SFV130C8]\]. The heterogeneity and complexity of AKI may compound difficulties in establishing good practice \[[@SFV130C9], [@SFV130C10]\].

Computerized clinical decision support (CCDS) has been promoted as a solution to these problems \[[@SFV130C11]\]. Unfortunately, there is a paucity of evidence of efficacy, and the wider literature has demonstrated problems with implementation and integration of other CCDS systems \[[@SFV130C12]--[@SFV130C14]\], with previous initiatives failing due to lack of user engagement in development and implementation \[[@SFV130C13]\].

There is a pressing need to evaluate not just quantitative outcomes but also user acceptability and its place within clinical workflows. Our study sought to identify those factors promoting or inhibiting use of an in-patient AKI CCDS system through end-user interviews and quantitative evaluation of their interaction with it. This study was part of a broader, mixed-methods evaluation that also included assessments of impact on practice and outcomes.

Materials and methods {#s2}
=====================

AKI CCDS context and functionality {#s2a}
----------------------------------

The study was conducted within our 1800-bed, multiple-site hospital. The renal unit, based at one of two acute sites, provides consultative input for AKI patients across the region.

In-patient records comprised written bedside documentation and an electronic patient record (EPR) for medicines management and test ordering and resulting (Cerner Millennium, Cerner Corporation, USA). The EPR already generated alerts interruptive of workflow (e.g. drug review prompts) and non-intrusive, background flags (e.g. noting previous *Clostridium difficile* infection).

An AKI CCDS was developed within the EPR by two co-authors (A.H., N.S.K.) to highlight in-patient AKI and link to guidance. An intrusive alert triggered when the individual patient\'s EPR was first accessed by medical staff after a serum creatinine (Cr) rise of ≥25 μmol/L/day. Correction to a daily rate of rise allowed for instances when Cr testing was less frequent. Setting of the trigger above diagnostic thresholds \[[@SFV130C9]\] was intended to minimize alert fatigue and pre-dated a national mandate \[[@SFV130C11]\]. In this exploratory study, only one AKI episode was triggered/admission, although the alert, itself, might present multiple times depending on user interaction with it.

The initial alert box highlighted possible AKI, noted the availability of clinical decision support (CDS) and hyperlinked to the local AKI protocol. A mandatory interaction then opened a menu window that required users to choose: To bypass the alert (if EPR accessed in error or by non-home team clinician),An exclusion: if receiving dialysis/end-of-life care, or'None of the above'.The alert could then be signed off, although optional links to local protocol and easy reference lists for essential assessments and investigations were available. The latter allowed quick ordering of test panels (e.g. essential bloods, urgent renal ultrasound). From initial alert to close out required at least four clicks. Option (i) made the alert dormant until the EPR was next accessed; the others de-activated it for the duration of the admission. All choices left a visible log on the biochemistry flowchart.

The following were excluded: The renal unit (due to erroneous alerts with dialysis),Critical and coronary care, transplantation areas (due to dialysis and the local spectrum of AKI),Patients \<18 years old.Triggers were prevented on patients who had deceased or discharged between the trigger Cr and first EPR access.

Implementation {#s2b}
--------------

Our study comprised three phases: Phase 1 (16 weeks): rolling implementation of the CCDS system across three pilot wards (Elderly Medicine, General Surgery, Internal Medicine) with usual practice continuing across the rest of the organization,A planned 8-week hiatus to allow CCDS refinement,Phase 2 (16 weeks): activation of the revised CCDS across all 64 target wards,Further CCDS refinement, if required,Phase 3 (4 weeks): to assess the impact of the revised tool across all 64 target wards.Publicity was undertaken through: On-site distribution of help sheets to Phase 1 wards,E-mail cascades, including the revised help sheet, 6 weeks prior to Phase 2,Incorporation within the standard training delivered to newly qualified doctors starting within the organization, 4 days prior to Phase 3.Study timelines were as follows: Phase 1: 12 August--2 December 2013,Phase 2: 8 April--29 July 2014,Phase 3: 8 August--5 September 2014.The longer than anticipated hiatus before Phase 2 was required for reconfiguration of the tool following feedback and for refinement of diagnostic algorithms.

Qualitative evaluation {#s2c}
----------------------

Procedures followed were in accordance with the ethical standards of the Local Research Ethics Committee (Ref. 12/NE/0278) and with the Helsinki Declaration of 1975, as revised in 2000.

Recruits were purposively sampled from those who had had experience of the alert. After informed consent, face-to-face interviews of ∼60 min duration were conducted by one of the co-authors, M.T.B. (an experienced qualitative researcher), on hospital premises, adopting an open-ended approach (i.e. without using leading questions, allowing the informant to take the lead and probing revealed themes in depth). Interviews were audio-recorded and transcribed using QSR Nvivo computer data analysis software (QSR International, Victoria, Australia) and analysed for identifiable themes according to the standard procedures of rigorous qualitative analysis (inductive coding, constant comparison, deviant case analysis) \[[@SFV130C15]\]. Recruitment continued in each phase until thematic saturation had occurred (i.e. when no new themes were emerging at successive interviews). The interviews were conducted and findings categorized within the framework of Normalization Process Theory (NPT) \[[@SFV130C16], [@SFV130C17]\]. NPT proposes that complex interventions only become integrated into existing practice through individual and collective implementation. This requires ongoing investment by individuals and groups in order to ensure continued use and occurs via four mechanisms: *Coherence*: how people make sense of what needs to be done.*Cognitive participation*: how relationships with others influence outcomes.*Collective action*: how people work together to make practices work.*Reflexive monitoring*: how people assess the impact of the new intervention.Each interview theme was therefore assigned to one of these four NPT mechanisms with participant statements extracted to highlight issues of significance for both end users and developers.

Phase 3 interviewees were limited to AKI CCDS naïve doctors. Inconvenience payments were offered based on hourly locum rates.

Quantitative evaluation of end-user interactions {#s2d}
------------------------------------------------

Three patient cohorts (*n* = 280, each) were identified for a separate evaluation of outcomes and practice. These comprised consecutively triggering patients from: (i) immediate go-live, Phase 2; (ii) 12 weeks post-go-live, Phase 2; and (iii) immediate go-live, Phase 3. Alert bypass rates were compared across patient cohorts using 'R' with a two-sample test for equality of proportions and a significance level of 5%. The use of exclusions and test panel ordering were recorded.

Results {#s3}
=======

Pre-Phase 2 CCDS changes {#s3a}
------------------------

The alert text was re-configured to include the trigger Cr and up to two preceding results depending on which was recognized as the reference value. The need to exercise clinical judgement about minor rises in very frequent Crs was emphasized. Greater prominence was given to guidance links within the menu window, which also now included a free text option for exclusions and a link to the drug chart, interaction with which was made mandatory.

Pre-Phase 3 CCDS changes {#s3b}
------------------------

Following Phase 2 feedback, alert interaction was made non-mandatory. Alert appearance was limited to five/admission with no repeat alert for any individual user for 4 h. The alert text was further simplified (figure [1](#SFV130F1){ref-type="fig"}a; figure [1](#SFV130F1){ref-type="fig"}b shows the subsequent menu window). Fig. 1.(**a**) Final, Phase 3 alert text. (**b**) Subsequent menu window.

Qualitative interview findings {#s3c}
------------------------------

Thematic saturation was achieved with 24 interviews (Table [1](#SFV130TB1){ref-type="table"}). Table 1.Numbers interviewed broken down by study phase, specialism and grade^a^Phase 1Phase 2Phase 3TotalMedicine Foundation trainee^b^2136 Speciality trainee^c^0101 Consultant^d^0404Surgery Foundation trainee4105 Speciality trainee0112 Consultant0000Care of the elderly Foundation trainee4206 Speciality trainee0000 Consultant0000Total1010424[^2][^3][^4][^5]

Trainees, in particular, found a coherent link between the alert and patient care, investing it with greater importance than other alerts due to its perceived relevance. Because of this, they were more likely to undertake earlier patient reassessment. A typical response is shown in Table [2](#SFV130TB2){ref-type="table"} (Quote 3.1.1---Phase 3, Respondent 1, Quote 1). Table 2.Interviewee quotesQuote3.1.1"It is quick and it is simple, it highlights something you should be looking at anyway but it is, you know, always nice to safety net yourself and make sure you definitely review even if it is something you are aware of at the time."2.3.1"I couldn\'t bypass it and I haven\'t had any training or been told about this form. There was no way I could bypass the form. I couldn\'t. I was so irritated by it I tried to bypass it and proceed and don\'t have the answers to subsequent questions ... I closed the whole system and went on to another system and then I asked the juniors what they had been doing."2.6.1"I think it\'s not that you don\'t trust it, it\'s just it\'s difficult to see the severity of it without seeing the blood results. The creatinine may have gone up by thirty or by one hundred and you still get the same warning. Obviously one needs a lot faster action than the other one really ... so I think that is why I want to see the blood results."2.6.2"So it pops up I look down the patient list see kind of how long ago their operation was and what they\'ve come in with, and then I go through and write down a list of the bloods that we haven\'t just done on the patient, then I click through the blood results and I like to look through their notes to see if they have changed anything, any medications and then I go and see them and look at the urine output. That is how it usually goes, then I send off the bloods or order the ultrasound."1.7.1"I didn\'t really go \[to see the patient\]. I just looked back to the last week and her U&Es were normal so I just ignored it \[laughs\]. I don\'t know if it was an earlier warning that hadn\'t been properly dealt with but it kept flagging up, but, yeah and in that instance there wasn\'t an AKI."3.2.1"To be completely honest it looks just like all the pop-ups we get. A lot of them are about medications we prescribed and they have been one off doses and they have stayed on the system and you deleted them. So ... and I have to admit some of them I have gotten used to just clicking dismiss and carrying on ... but I have noticed when I\'ve had this one and I have gone and actually looked at their bloods."3.2.2"I thought it was great ... it just means you definitely look at it twice and make sure it wasn\'t something you needed to do intervention wise."

Actions prompted by the alert did not always get explicitly documented as such because they were perceived as normal medical activities.

Mandated interaction clearly irritated users, with the highest emotional response coming from senior staff. Unlike trainees who worked together to navigate the CCDS, senior staff struggled to use it. Apart from having 'too many clicks', it was cited as an insult to their knowledge; suspicion was expressed of a clandestine audit process (Table [2](#SFV130TB2){ref-type="table"}, Quote 2.3.1).

This response illustrated the impact on workflow of alerts that could not be immediately dismissed or minimized to enable the primary activity to continue. Because of more frequent use, trainees often found ways to bypass it. However, rather than preventing the alert from appearing again, bypassing it simply hid it until the next time the patient\'s chart was accessed. Workflow interruption was the dominant reason for dislike of the alert but reflected interviewees\' antipathy to all EPR pop-ups.

A major driver for alert dismissal was users\' need to view historical biochemistry to allow clinical decision-making and prioritization. This came at the expense of lack of engagement with guidance and test ordering. Even when Cr data were introduced into the Phase 2 alert, users still referred back to more comprehensive data to assess alert credibility. Technical limitations prevented presentation of detailed Cr data within the alert box (Table [2](#SFV130TB2){ref-type="table"}, Quote 2.6.1).

In the main, the alert was seen as credible and enhanced cognitive participation (Table [2](#SFV130TB2){ref-type="table"}, Quote 2.6.2). Alert credibility was sometimes strained, though, when it was felt to be too sensitive. Lack of awareness of even lower diagnostic thresholds for AKI was evident, but interviewees also identified instances when an alert appeared not to be associated with an elevation in serum Cr (Table [2](#SFV130TB2){ref-type="table"}, Quote 1.7.1). This may have been explained by unaccounted anomalies in the alert (e.g. patient transfer from a non-alerting venue to a study ward) or by a recurring alert that had just been bypassed and ignored by others.

Participants openly expressed concern about alert fatigue (Table [2](#SFV130TB2){ref-type="table"}, Quote 3.2.1). The only new interview finding in Phase 3 was that the revised alert proved to be more acceptable because of increased ease of dismissal (Table [2](#SFV130TB2){ref-type="table"}, Quote 3.2.2).

Finally, it was evident that at least some users were unaware of CDS functionality downstream of the initial alert (e.g. test ordering, best practice checklists); when its availability was pointed out to them they did feel that this was of potential use.

Quantitative evaluation of end-user interactions {#s3d}
------------------------------------------------

High rates of bypassing were found and increased as Phase 2 progressed (Table [3](#SFV130TB3){ref-type="table"}). Free text exclusion comments often queried the trigger threshold (e.g. 'no rise'), suggested prior knowledge of AKI (e.g. 'known acute renal failure post CABG') or offered an alternative explanation (e.g. 'previous renal transplant', 'pregnancy/postnatal'). Minimal use of test panel ordering was evident in the three patient cohorts from (i) immediate go-live, Phase 2 cohort (5.4%), (ii) 12 weeks post-go-live, Phase 2 (7.5%), and (iii) immediate go-live, Phase 3 (1.1%). Table 3.End-user use of bypass function across study phasesImmediate go-live, Phase 212 weeks post-go-live, Phase 2Total number of alert forms completed9981101Total number of bypasses788918Alert form bypass rate (%)79\*83\*Median number of bypasses per patient33Median number of bypasses per doctor2 (1--22)2 (1--20)[^6][^7][^8]

Discussion {#s4}
==========

CCDS for AKI has been widely promoted \[[@SFV130C11], [@SFV130C18]\]. Although a uniform detection algorithm is now mandated across England and Wales \[[@SFV130C11]\], the end-user interface may still vary, for instance, in terms of alert intrusion, its mode of delivery and mandation of interaction. Even a single, uniform interface may not suit all circumstances. There is, therefore, a pressing and well-recognized \[[@SFV130C1], [@SFV130C18]\] need for evaluation of implementation, function and impact on practice. The evidence, however, remains limited and conflicting.

One prospective, single-centre, intensive care study found that interruptive text alerts led to more timely intervention and more rapid resolution of AKI \[[@SFV130C19]\]. However, over 90% of alerts were generated for changes in urine output, alone, suggesting that the intervention was addressing an early, pre-renal response. Moreover, mortality and the need for renal support were unaffected. Another single-centre, parallel group study \[[@SFV130C20]\] randomized patients with serum Cr-based AKI to usual care or an interruptive text alert to their clinician and found no difference in outcome, but with some evidence of increased resource utilization. Neither study explored end-user acceptability or the social context of their alerts.

Even when beneficial \[[@SFV130C21]--[@SFV130C23]\], other CCDS systems may have negative impacts including delayed treatment \[[@SFV130C14]\]. The limited evidence of patient benefit was illustrated in one review \[[@SFV130C24]\] that found only 57% of studies affected user behaviour with only 30% able to demonstrate an effect on patient outcomes. The negative impact of top-down solutions, without 'end-user pull' in tailoring CCDS, has been emphasized \[[@SFV130C13], [@SFV130C25]\], but specific points of end-user dissatisfaction include alert fatigue \[[@SFV130C12], [@SFV130C26]--[@SFV130C29]\], mandated responses (that are frequently bypassed if workflows are disrupted \[[@SFV130C30]\]) and the complexity of clinical decision-making---far from facilitating patient management, CCDS may complicate it by forcing the user to interpret the solution they have been presented with \[[@SFV130C13]\]. Without understanding how technologies, people and organizations dynamically interact \[[@SFV130C31], [@SFV130C32]\] and the importance of pre-existing attitudes \[[@SFV130C33]\], it will remain unclear how to tailor and integrate more complex CCDS (such as for AKI) within existing practice.

We believe our study is the first to undertake qualitative evaluation of an AKI CCDS system and has revealed precisely those themes warned of in the generic literature---alert fatigue, user dissatisfaction and antipathy to mandatory interactions and intrusion.

Development of our system included extensive pilot work, but the broader picture of discontent was only revealed later. Additionally, our preconceived belief in the advantages of a visible audit trail within the biochemistry flowsheet and of exclusion recording to block further alerts was negated by antipathy to mandated interaction which these apparent benefits required. Although mindful of the risks of top-down solutions, our study has revealed the need for an end-user responsive process that, we feel, must extend well beyond initial scoping and implementation.

We found limited engagement with CDS functionality, downstream of the original alert (e.g. test ordering). Lack of awareness was evident, but we speculate that the drive for rapid alert dismissal was an important explanatory factor---when this was facilitated in Phase 3, test panel ordering and the rate of form completion fell off sharply.

An impression of over-sensitive alerting affected the tool\'s credibility for some. Although this may have reflected poor awareness of current diagnostic thresholds, many patients may never achieve a Cr higher than the one initially triggering even a Stage 1 AKI alert \[[@SFV130C20]\]. If alerts are only being generated when AKI is already resolving, one can speculate upon the negative impact on even initially positive end users.

Our study has a number of caveats.

Firstly, our tool was developed in-house and required experiential learning to meet some user demands. Although not an explicit interview finding, delays may have affected the tool\'s credibility. Secondly, the pre-Phase 2 educational roll-out proved to have had limited reach, requiring a supplementary cascade after 10 weeks; this, we feel, probably reflected the shortfall in educational resource needed to inform a large, multiple-site organization. Thirdly, our CCDS was not intended as an exhaustive surveillance tool. Missed episodes of AKI (due to the higher-than-diagnostic trigger threshold or because this was a repeat AKI episode) might have affected credibility, although this was not apparent in interviews. Fourthly, users were only interviewed once, so temporal changes in experience may have been missed. Finally, we acknowledge that user culture in Phase 2 might have been affected by discussion with pilot ward participants, although we feel it would have been difficult to avoid this in a single-centre study.

We believe that our study offers important lessons about the implementation, integration and acceptability of AKI CCDS. Its significance was its congruency with medical practice, appearing to prompt earlier patient reassessment at least amongst some trainees. Our study has, however, also revealed those themes that have affected other CCDS implementations. Systems intruding on workflow, particularly involving complex or mandatory interactions, may not be sustainable even if there has been a positive impact on care. Although conducted in a single institution within the National Health Service of England and Wales, we believe that our study has relevance to other healthcare communities, all of whom will face common challenges of clinical prioritization, efficiency of workflow and effective team-working, even if the solutions to these may differ. Further evaluation is needed of the optimal balance between intrusion and clinical benefit as well as of the applicability of our findings across different information technology capabilities and clinical settings.
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[^2]: ^a^No participant was interviewed more than once. Forty-six staff were approached about participation. The most common reason for refusal was lack of time.

[^3]: ^b^Trainees within 2 years of post-graduation.

[^4]: ^c^Senior trainees.

[^5]: ^d^Senior clinicians ≡ attending/staff clinicians.

[^6]: \**P* = 0.01.

[^7]: Each alert form could be completed (i.e. closed out) by bypassing, recording an exclusion or recording an acknowledgment of the form (by clicking option (iii): 'None of the above'---see the text for details).

[^8]: In Phase 3, immediate alert dismissal avoided the need for subsequent interaction with the CCDS (the AKI form was completed in only 3/280 alerting patients).
